Φορτώνει......
Evolving consensus for immunomodulatory therapy in non-infectious uveitis during the COVID-19 pandemic
BACKGROUND: Immunomodulatory therapy (IMT) is often considered for systemic treatment of non-infectious uveitis (NIU). During the evolving coronavirus disease-2019 (COVID-19) pandemic, given the concerns related to IMT and the increased risk of infections, an urgent need for guidance on the manageme...
Αποθηκεύτηκε σε:
| Τόπος έκδοσης: | Br J Ophthalmol |
|---|---|
| Κύριοι συγγραφείς: | , , , , , , , , , , , , , , , , , |
| Μορφή: | Artigo |
| Γλώσσα: | Inglês |
| Έκδοση: |
BMJ Publishing Group
2020
|
| Θέματα: | |
| Διαθέσιμο Online: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7313529/ https://ncbi.nlm.nih.gov/pubmed/32586933 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1136/bjophthalmol-2020-316776 |
| Ετικέτες: |
Προσθήκη ετικέτας
Δεν υπάρχουν, Καταχωρήστε ετικέτα πρώτοι!
|